Macrolide‐Resistant Pneumococcal Endocarditis and Epidural Abscess that Develop during Erythromycin Therapy
- 15 January 2003
- journal article
- case report
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 36 (2) , e19-e25
- https://doi.org/10.1086/344965
Abstract
Suppurative complications of Streptococcus pneumoniae infections have become uncommon in the antibiotic era. We report a case of pneumococcal bacteremia and pneumonia complicated with epidural abscess and endocarditis in which macrolide resistance (the MLSB phenotype) emerged during erythromycin therapy. Genetic determinants known to mediate the most common mechanisms of macrolide resistance (methylation of the 23S rRNA and antibiotic efflux) were not detected by polymerase chain reaction or DNA hybridization. Sequence analysis of the DNA encoding the 23S rRNA of the macrolide-resistant isolate from the patient demonstrated the replacement of adenine by thymine at position 2058 (A2058T) in 2 of 4 alleles. Clinicians should be alert to the possibility of the emergence of resistance during macrolide therapy for community-acquired pneumonia, particularly if suppurative complications of pneumococcal infection are suspected.Keywords
This publication has 54 references indexed in Scilit:
- Emergence of Macrolide Resistance during Treatment of Pneumococcal PneumoniaNew England Journal of Medicine, 2002
- Mechanisms of Resistance to Macrolides and Lincosamides: Nature of the Resistance Elements and Their Clinical ImplicationsClinical Infectious Diseases, 2002
- Macrolide Resistance Among Invasive Streptococcus pneumoniae IsolatesPublished by American Medical Association (AMA) ,2001
- Identification of an erm (A) Erythromycin Resistance Methylase Gene in Streptococcus pneumoniae Isolated in GreeceAntimicrobial Agents and Chemotherapy, 2001
- Increasing Prevalence of Multidrug-ResistantStreptococcus pneumoniaein the United StatesNew England Journal of Medicine, 2000
- Recent developments in the area of macrolide antibioticsExpert Opinion on Therapeutic Patents, 2000
- The Continued Emergence of Drug-Resistant Streptococcus pneumoniae in the United States: An Update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance SystemThe Journal of Infectious Diseases, 1996
- Novel mechanism of macrolide resistance in Streptococcus pneumoniaeDiagnostic Microbiology and Infectious Disease, 1996
- Type 6 Pneumococcus Resistant to Erythromycin and LincomycinNew England Journal of Medicine, 1967
- PNEUMOCOCCUS RESISTANT TO ERYTHROMYCIN AND LINCOMYCINThe Lancet, 1967